---
figid: PMC7962349__13046_2021_1893_Fig7_HTML
figlink: pmc/articles/PMC7962349/figure/Fig7/
number: F7
caption: Intervention of combined drugs on the TME. Rapamycin (RapA) is a mTOR inhibitor
  that inhibits tumour proliferation through anti-angiogenesis and can be enhanced
  in combination with cisplatin. Cisplatin combined with paclitaxel inhibits tumour
  invasion. The combination of everolimus and sunitinib can affect stromal cells and
  cancer cells in the TME. Antiangiogenic drugs (AADs) combined with carnitine palmitoyltransferase
  1A (CPT1) inhibitors significantly inhibited fatty acid oxidation (FAO) -induced
  cell proliferation and angiogenesis. Ginsenoside Rg3 combined with cisplatin can
  inhibit epithelial-mesenchymal transition (EMT) of tumour cells. Hedgehog (HH) signalling
  pathway inhibitors combined with bufalin can inhibit tumour proliferation. Tranilast
  can dow-regulate CAF activity, promote vascular normalization, and help docetaxel
  micelles (DTX-ms) reach tumour tissue through veins and kill tumour cells. Sorafenib
  combined with bufalin affects the tumour vascular microenvironment through targeting
  the mTOR/VEGF signalling pathway
pmcid: PMC7962349
papertitle: Underlying mechanisms and drug intervention strategies for the tumour
  microenvironment.
reftext: Haoze Li, et al. J Exp Clin Cancer Res. 2021;40:97.
pmc_ranked_result_index: '4839'
pathway_score: 0.9326137
filename: 13046_2021_1893_Fig7_HTML.jpg
figtitle: Intervention of combined drugs on the TME
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7962349__13046_2021_1893_Fig7_HTML.html
  '@type': Dataset
  description: Intervention of combined drugs on the TME. Rapamycin (RapA) is a mTOR
    inhibitor that inhibits tumour proliferation through anti-angiogenesis and can
    be enhanced in combination with cisplatin. Cisplatin combined with paclitaxel
    inhibits tumour invasion. The combination of everolimus and sunitinib can affect
    stromal cells and cancer cells in the TME. Antiangiogenic drugs (AADs) combined
    with carnitine palmitoyltransferase 1A (CPT1) inhibitors significantly inhibited
    fatty acid oxidation (FAO) -induced cell proliferation and angiogenesis. Ginsenoside
    Rg3 combined with cisplatin can inhibit epithelial-mesenchymal transition (EMT)
    of tumour cells. Hedgehog (HH) signalling pathway inhibitors combined with bufalin
    can inhibit tumour proliferation. Tranilast can dow-regulate CAF activity, promote
    vascular normalization, and help docetaxel micelles (DTX-ms) reach tumour tissue
    through veins and kill tumour cells. Sorafenib combined with bufalin affects the
    tumour vascular microenvironment through targeting the mTOR/VEGF signalling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - MTOR
  - Sorafenib
  - Rapamycin
  - Cisplatin
  - Paclitaxel
  - DTX
  - Ginsenoside
  - Rg3
  - Everolimus
  - Sunitinib
genes:
- word: (VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: (VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: (VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: (VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: (VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: MTÃ“R
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
chemicals:
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Rapamycin
  source: MESH
  identifier: D020123
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Paclitaxel
  source: MESH
  identifier: D017239
- word: DTX
  source: MESH
  identifier: C081705
- word: Ginsenoside
  source: MESH
  identifier: D036145
- word: Rg3
  source: MESH
  identifier: C097367
- word: Everolimus
  source: MESH
  identifier: C107135
- word: Sunitinib
  source: MESH
  identifier: C473478
diseases: []
figid_alias: PMC7962349__F7
redirect_from: /figures/PMC7962349__F7
figtype: Figure
---
